angina pectoris |
Disease ID | 1354 |
---|---|
Disease | angina pectoris |
Definition | The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. |
Synonym | angina angina (disorder) angina pain angina pectoris (disorder) angina pectoris (disorder) [ambiguous] angina pectoris [disease/finding] angina pectoris nos angina pectoris nos (disorder) angina pectoris, nos angina, cardiac angina, nos anginal pain anginal syndrome anginas angor pectoris ap - angina pectoris cardiac angina chest pain - cardiac ischaemic chest pain ischaemic chest pain (disorder) ischaemic heart disease - angina ischemic chest pain ischemic chest pain (finding) ischemic heart disease - angina pain angina pectoris angina stenocardia stenocardia (disorder) stenocardias |
UMLS | C0002962 |
MeSH | |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:53) C0002965 | unstable angina pectoris | 14 C0002965 | unstable angina | 14 C0010068 | coronary artery disease | 12 C0020538 | hypertension | 10 C0004153 | atherosclerosis | 6 C0011847 | diabetes | 6 C0022116 | ischemia | 5 C0027051 | myocardial infarct | 5 C0027051 | myocardial infarction | 5 C0010054 | coronary atherosclerosis | 4 C0042373 | vascular disease | 4 C0151744 | myocardial ischemia | 3 C0007222 | cardiovascular disease | 3 C0022116 | ischaemia | 3 C0010073 | coronary artery spasm | 3 C0155626 | acute myocardial infarction | 3 C0018801 | heart failure | 3 C0018799 | heart disease | 2 C0151744 | myocardial ischaemia | 2 C0003850 | arteriosclerosis | 2 C0022658 | nephropathy | 2 C0042373 | vascular diseases | 2 C0010068 | coronary disease | 2 C0011849 | diabetes mellitus | 2 C0006267 | bronchiectasis | 2 C0007102 | colon cancer | 1 C0029408 | osteoarthritis | 1 C0020456 | hyperglycemia | 1 C0011570 | depression | 1 C0034150 | purpura | 1 C0010073 | coronary spasm | 1 C0040156 | thyrotoxicosis | 1 C1442837 | myocardial necrosis | 1 C0852949 | arterial disease | 1 C0043117 | idiopathic thrombocytopenic purpura | 1 C0007222 | cardiovascular diseases | 1 C0278553 | recurrent colon cancer | 1 C0151744 | ischaemic heart disease | 1 C1135191 | systolic heart failure | 1 C0018916 | hemangioma | 1 C0038531 | subclavian steal syndrome | 1 C0878544 | cardiomyopathy | 1 C0948265 | metabolic syndrome | 1 C0085278 | antiphospholipid syndrome | 1 C0264683 | coronary atheroma | 1 C0004030 | aspergillosis | 1 C0020542 | pulmonary hypertension | 1 C0040053 | thrombus | 1 C0002726 | amyloidosis | 1 C0018824 | valvular heart disease | 1 C0398625 | protein c deficiency | 1 C0040053 | thrombosis | 1 C0020443 | hypercholesterolaemia | 1 |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:2) |
Inferring Gene | Entrez_id | Symbol | Resource(Total Genes:16) 1361 | CPB2 | infer 1535 | CYBA | infer 2243 | FGA | infer 2244 | FGB | infer 2811 | GP1BA | infer 3675 | ITGA3 | infer 4314 | MMP3 | infer 4318 | MMP9 | infer 7941 | PLA2G7 | infer 5444 | PON1 | infer 6872 | TAF1 | infer 217 | ALDH2 | infer 348 | APOE | infer 3383 | ICAM1 | infer 3569 | IL6 | infer 5175 | PECAM1 | infer |
Text Mined Gene | (Waiting for update.) |
Locus | (Waiting for update.) |
Disease ID | 1354 |
---|---|
Disease | angina pectoris |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:22) C0010068 | coronary artery disease | 12 C0020538 | hypertension | 10 C0030193 | pain | 10 C0011847 | diabetes | 6 C0008031 | chest pain | 6 C0022116 | ischemia | 5 C0010054 | coronary atherosclerosis | 4 C0037763 | spasm | 4 C0018801 | heart failure | 3 C0151744 | myocardial ischemia | 3 C0022116 | ischaemia | 3 C0856169 | endothelial dysfunction | 2 C0010068 | coronary disease | 2 C0013404 | dyspnea | 2 C0005750 | stasis syndrome | 1 C0242339 | dyslipidemia | 1 C0010073 | coronary spasm | 1 C0011570 | depression | 1 C0422833 | ent symptoms | 1 C0040053 | thrombus | 1 C1839611 | n syndrome | 1 C0542052 | coronary insufficiency | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:47) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0002962 | amiloride | D000584 | 2609-46-3 | angina pectoris | MESH:D000787 | therapeutic | 8062500 | ||
C0002962 | amitriptyline | D000639 | 50-48-6 | angina pectoris | MESH:D000787 | therapeutic | 9591892 | ||
C0002962 | amlodipine | D017311 | 88150-42-9 | angina pectoris | MESH:D000787 | therapeutic | 10932030 | ||
C0002962 | atenolol | D001262 | 29122-68-7 | angina pectoris | MESH:D000787 | therapeutic | 101223 | ||
C0002962 | atropine | D001285 | 51-55-8 | angina pectoris | MESH:D000787 | therapeutic | 6305298 | ||
C0002962 | betaxolol | D015784 | 63659-18-7 | angina pectoris | MESH:D000787 | therapeutic | 14559135 | ||
C0002962 | bisoprolol | D017298 | 66722-44-9 | angina pectoris | MESH:D000787 | therapeutic | 2439788 | ||
C0002962 | bleomycin | D001761 | 11056-06-7 | angina pectoris | MESH:D000787 | marker/mechanism | 2456930 | ||
C0002962 | celecoxib | D000068579 | - | angina pectoris | MESH:D000787 | marker/mechanism | 16681880 | ||
C0002962 | cyclophosphamide | D003520 | 50-18-0 | angina pectoris | MESH:D000787 | marker/mechanism | 18849242 | ||
C0002962 | diatrizoate | D003973 | 117-96-4 | angina pectoris | MESH:D000787 | marker/mechanism | 9408613 | ||
C0002962 | cisplatin | D002945 | 15663-27-1 | angina pectoris | MESH:D000787 | marker/mechanism | 10397083 | ||
C0002962 | diclofenac | D004008 | 15307-86-5 | angina pectoris | MESH:D000787 | marker/mechanism | 9220183 | ||
C0002962 | digoxin | D004077 | 20830-75-5 | angina pectoris | MESH:D000787 | therapeutic | 2912410 | ||
C0002962 | dihydroergotamine | D004087 | 511-12-6 | angina pectoris | MESH:D000787 | marker/mechanism | 8308831 | ||
C0002962 | diltiazem | D004110 | 42399-41-7 | angina pectoris | MESH:D000787 | therapeutic | 10027656 | ||
C0002962 | fluorouracil | D005472 | 51-21-8 | angina pectoris | MESH:D000787 | marker/mechanism | 12402434 | ||
C0002962 | leucovorin | D002955 | 1958/5/9 | angina pectoris | MESH:D000787 | marker/mechanism | 15668828 | ||
C0002962 | indomethacin | D007213 | 53-86-1 | angina pectoris | MESH:D000787 | marker/mechanism | 9220183 | ||
C0002962 | isradipine | D017275 | 75695-93-1 | angina pectoris | MESH:D000787 | marker/mechanism | 11002857 | ||
C0002962 | isradipine | D017275 | 75695-93-1 | angina pectoris | MESH:D000787 | therapeutic | 1703598 | ||
C0002962 | labetalol | D007741 | 36894-69-6 | angina pectoris | MESH:D000787 | therapeutic | 2908732 | ||
C0002962 | leuprolide | D016729 | 53714-56-0 | angina pectoris | MESH:D000787 | marker/mechanism | 8030717 | ||
C0002962 | metoprolol | D008790 | 37350-58-6 | angina pectoris | MESH:D000787 | therapeutic | 21112460 | ||
C0002962 | mifepristone | D015735 | 84371-65-3 | angina pectoris | MESH:D000787 | marker/mechanism | 11187221 | ||
C0002962 | nelfinavir | D019888 | 159989-64-7 | angina pectoris | MESH:D000787 | marker/mechanism | 18025881 | ||
C0002962 | nisoldipine | D015737 | 63675-72-9 | angina pectoris | MESH:D000787 | therapeutic | 11720635 | ||
C0002962 | nitric oxide | D009569 | 10102-43-9 | angina pectoris | MESH:D000787 | therapeutic | 1686696 | ||
C0002962 | phenylephrine | D010656 | 59-42-7 | angina pectoris | MESH:D000787 | marker/mechanism | 10389447 | ||
C0002962 | prazosin | D011224 | 19216-56-9 | angina pectoris | MESH:D000787 | marker/mechanism | 472855 | ||
C0002962 | propranolol | D011433 | 525-66-6 | angina pectoris | MESH:D000787 | marker/mechanism | 12113709 | ||
C0002962 | propranolol | D011433 | 525-66-6 | angina pectoris | MESH:D000787 | therapeutic | 101223 | ||
C0002962 | epoprostenol | D011464 | 35121-78-9 | angina pectoris | MESH:D000787 | therapeutic | 2433921 | ||
C0002962 | ramipril | D017257 | 87333-19-5 | angina pectoris | MESH:D000787 | therapeutic | 10732883 | ||
C0002962 | ranolazine | D000069458 | - | angina pectoris | MESH:D000787 | therapeutic | 11975803 | ||
C0002962 | rosiglitazone | C089730 | - | angina pectoris | MESH:D000787 | marker/mechanism | 19591532 | ||
C0002962 | sotalol | D013015 | 3930-20-9 | angina pectoris | MESH:D000787 | marker/mechanism | 7171401 | ||
C0002962 | sotalol | D013015 | 3930-20-9 | angina pectoris | MESH:D000787 | therapeutic | 1360557 | ||
C0002962 | dextrothyroxine | D003918 | 51-49-0 | angina pectoris | MESH:D000787 | marker/mechanism | 5818672 | ||
C0002962 | ticlopidine | D013988 | 55142-85-3 | angina pectoris | MESH:D000787 | therapeutic | 19309387 | ||
C0002962 | timolol | D013999 | 26839-75-8 | angina pectoris | MESH:D000787 | therapeutic | 2508936 | ||
C0002962 | vinblastine | D014747 | 865-21-4 | angina pectoris | MESH:D000787 | marker/mechanism | 2456930 | ||
C0002962 | vincristine | D014750 | - | angina pectoris | MESH:D000787 | marker/mechanism | 11724093 | ||
C0002962 | vindesine | D014751 | 53643-48-4 | angina pectoris | MESH:D000787 | marker/mechanism | 3948198 | ||
C0002962 | vinorelbine | C030852 | 71486-22-1 | angina pectoris | MESH:D000787 | marker/mechanism | 10731757 | ||
C0002962 | vitamin e | D014810 | 1406-18-4 | angina pectoris | MESH:D000787 | marker/mechanism | 15562867 | ||
C0002962 | vitamin e | D014810 | 1406-18-4 | angina pectoris | MESH:D000787 | therapeutic | 9822095 |
FDA approved drug and dosage information(Total Drugs:3) | ||||||||
---|---|---|---|---|---|---|---|---|
DiseaseID | Drug_name | active_ingredients | strength | Dosage Form/Route | Marketing Status | TE code | RLD | RS |
MESH:D000787 | celebrex | celecoxib | 100MG | CAPSULE;ORAL | Prescription | AB | Yes | No |
MESH:D000787 | celebrex | celecoxib | 100MG | CAPSULE;ORAL | Prescription | None | No | No |
MESH:D000787 | inomax | nitric oxide | 100PPM Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons | GAS;INHALATION | Discontinued | None | Yes | No |
FDA labeling changes(Total Drugs:3) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DiseaseID | Pediatric_Labeling_Date | Trade_Name | Generic_Name_or_Proper_Name | Indications Studied | Label Changes Summary | Product Labeling | BPCA(B) | PREA(P) | BPCA(B) and PREA(P) | Pediatric Rule (R) | Sponsor | Pediatric Exclusivity Granted Date | NNPS |
MESH:D000787 | 12/15/2006 | celebrex | celecoxib | Relief of the signs and symptoms of juvenile rheumatoid arthritis (JRA) | New indication in 2 years and older Has not been studied in patients < 2 years, in patients with body weight < 10 kg, or in patients with active systemic features Celecoxib should be used only with caution in patients with systemic onset JRA due to the risk for serious adverse reactions including the risk of disseminated intravascular coagulation The long-term cardiovascular toxicity in children has not been evaluated; it is unknown if the long-term risk may be similar to that seen in adults New 50 mg capsule developed Information on adding contents of a capsule to applesauce. for patients with difficulty swallowing capsules Information on dose, clinical studies, PK parameters, AEs | Labeling | B | - | - | - | Pfizer | 08/23/2006 | FALSE' |
MESH:D000787 | 12/15/2006 | celebrex | celecoxib | Relief of the signs and symptoms of juvenile rheumatoid arthritis (JRA) | New indication in 2 years and older Has not been studied in patients < 2 years, in patients with body weight < 10 kg, or in patients with active systemic features Celecoxib should be used only with caution in patients with systemic onset JRA due to the risk for serious adverse reactions including the risk of disseminated intravascular coagulation The long-term cardiovascular toxicity in children has not been evaluated; it is unknown if the long-term risk may be similar to that seen in adults New 50 mg capsule developed Information on adding contents of a capsule to applesauce. for patients with difficulty swallowing capsules Information on dose, clinical studies, PK parameters, AEs | Labeling | B | - | - | - | Pfizer | 08/23/2006 | FALSE' |
MESH:D000787 | 12/21/2010 | inomax | nitric oxide | Prevention of bronchopulmonary dysplasia | INOmax is not indicated for prevention of BPD in preterm neonates d 34 weeks gestational age.Efficacy for the prevention of BPD in preterm infants was not established in three ldouble-blind, placebo-controlled clinical trials in a total of 2,149 preterm infants Information on clinical trials, adverse reaction | Labeling | B | - | - | - | INO Therapeutics | 2/11/2010 | FALSE' |